Evaluation of the Spectra Optia PMN Cell Collection Procedure

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Granulocyte/ Polymorphonuclear Cells
Interventions
DEVICE

Granulocyte/Polymorphonuclear Cell Collection (COBE Spectra System)

In Arm 1 the first PMN cell collection will be performed using the Spectra Optia System and the second PMN cell collection using the COBE Spectra System.

DEVICE

Granulocyte/Polymorphonuclear Cell Collection (Spectra Optia System)

In Arm 2 the first PMN cell collection will be performed using the COBE Spectra System and the second PMN cell collection using the Spectra Optia System.

Trial Locations (3)

53233

Blood Centers of Wisconsin, Milwaukee

80230

Bonfils Blood Center, Denver

45267-0055

Hoxworth Blood Center, Cincinnati

All Listed Sponsors
lead

Terumo BCT

INDUSTRY

NCT01805180 - Evaluation of the Spectra Optia PMN Cell Collection Procedure | Biotech Hunter | Biotech Hunter